Palliative Care in Heart Failure
Completed · Not applicable
Conditions studied: Heart Failure, Heart Diseases, Cardiovascular Diseases
In brief
The primary aim of the PAL-HF trial is to assess the impact of an interdisciplinary palliative care intervention combined with usual heart failure management on health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy with Palliative Care Subscale.
Key facts
- Study ID
- NCT01589601
- Run by
- Duke University
- People needed
- 150
- Starts
- 2012-08-01
- Expected to finish
- 2016-02-01
- Last updated by the study team
- 2019-08-28
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Duke University Hospital inpatient adults
- Hospitalization for acute decompensated heart failure
- Dyspnea (shortness of breath) at rest or minimal exertion plus at least 1 sign of volume overload
- Previous heart failure hospitalization within the past 1 year
- At significant risk of dying from heart failure in the next 6 months
- Anticipated discharge from hospital with anticipated ability to return to outpatient follow-up appointments
You may not qualify if…
- Are not an inpatient at Duke University Hospital
- Acute coronary syndrome within 30 days
- Cardiac resynchronization therapy (CRT) within the past 3 months or current plan to implant CRT device
- Active myocarditis, constrictive pericarditis
- Severe stenotic valvular disease amenable to surgical intervention
- Anticipated heart transplant or ventricular assist device within 6 months
- Renal replacement therapy
- Non-cardiac terminal illness
- Women who are pregnant or planning to become pregnant
- Inability to comply with study protocol
- Are not proficient in the English language
Where it is running
- Duke University Hospital — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.